FDA Adverse Event Injury Summary report: N

UNIVERSAL II

MDR report key: 796615 · Received December 16, 2006

Report

Report Number
2028159-2006-00505
Event Type
Injury
Date Received
December 16, 2006
Date of Event
October 30, 2006
Report Date
November 16, 2006
Manufacturer
ALCON - IRVINE TECHNOLOGY CTR
Product Code
HQE
Removal / Correction Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PL
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATION, INCLUDING ROOT CAUSE ANALYSIS, IS IN PROGRESS.

Description of Event or Problem · 1

A DOCTOR INITIALLY REPORTED GROWTH OF PSEUDOMONAS AERUGINOSA FROM PIECE OF (SYSTEM'S) INTERNAL TUBES IN MICROBIOLOGICAL MEDIUM, POTENTIALLY CAUSING EYE INFLAMMATION. INITIAL REPORT WAS FILED AS MFG. RPT. # 2028159-2006-00493. 11/16/2006: ADDITIONAL INFORMATION RECEIVED FROM THE DOCTOR NOTED THERE WERE TEN CASES OCCURRING BETWEEN 10/2006 AND 11/2006. THESE ADDITIONAL 9 CASES REPORTED AS MFG. RPT. #: 2028159-2006-00502, 2028159-2006-00503, 2028159-2006-00504, 2028159-2006-00505, 2028159-2006-00506, 2028159-2006-00507, 2028159-2006-00508, 202815-2006-00509, 2028159-2006-00510. NO CULTURES WERE DONE BECAUSE IN NORMAL PROCEDURE THE PATIENT IS TAKING ANTIBIOTICS AFTER SURGERY. THE INFLAMMATION OCCURRED THREE TO FOUR HOURS AFTER SURGERY. 11/28/2006: ADDITIONAL INFORMATION FROM THE DOCTOR INDICATED HAD: "CORNEAL EDEMA. ANTERIOR CHAMBER FILLED WITH NUMEROUS INFLAMMATORY CELLS. FIBRINOUS MEMBRANES PROLIFERATING IN THE PUPILLARY APERTURE EXTEND TO THE IRIS AND TOUCH THE CORNEA WITH DIGITATE PROCESSES. IN THE ANTERIOR CHAMBER A CONGLOMERATE OF GELATINOUS TISSUE LOCATED IN PROJECTION OF THE PUPILLARY APERTURE." THIS WAS REASON FOR PROLONGED HOSPITALIZATION. NORMAL STAY IS ONE DAY. THIS PATIENT'S EVENT DURATION WAS 4 DAYS. OUTCOME IS GOOD. THERE WAS NO UNPLANNED MEDICAL OR SURGICAL INTERVENTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNIVERSAL II PHACOEMULSIFICATION-ASPIRATION SYSTEM HQE ALCON - IRVINE TECHNOLOGY CTR UNIV II PEA NA

Patients

Seq Age Sex Outcome Treatment
1 71 YR Hospitalization